to repost. Homotaurine has been in development for years and years. Yet, the results in the figure below
. 120%? Yeah! Oral inexpensive supplement? Unbelievable. Works in 44? Why, yes!
34? Not as sure.
We know from other trials that a ~1.3 point treatment effect on CDR is big.
In the figure this was enough to almost entirely stop decline.
Of course, generation 2 of this product has even greater brain availability.
There is just so much great news that is on the horizon and has already arrived.
Simultaneously targeting multiple amyloid pathways is already highly plausible.
Will the new frontier no longer be stopping AD, but reversing it?
Then add in tau inhibitors? Yea!
Update, gains were sustained out for another 52 weeks (130 weeks) in the trial extension.Wow!!!
"In APOE4/4 patients, tramiprosate 150mg BID exhibited sustained cognitive and functional benefits over 2.5 years,
compared to the “delayed start” group who initially received placebo."
Nice if they could have shown us the figure, the write-up is somewhat confusing about the actual results.
Has this result been published?https://alzheon.com/clinical-effects-tr ... ion-study/
Here is the link for free journal articles on Tramiprosate. These were hard ones to find (for free anyways).https://www.jpreventionalzheimer.com/al ... tml?search
Um, we really aren't supposed to push products here, but 11 pounds for homotaurine? 35% discount today.
Is there going to be any payola left for me at 11 pounds? No?https://www.supersmart.com/en/shop/brai ... ement-0661https://alzheon.com/clinical-data/https://alzheon.com/wp-content/uploads/ ... _91918.png
Sorry everyone I realize that this has been talked about on other threads, though it is just too good not
You do not have the required permissions to view the files attached to this post.